Skip to main content
. 2022 Dec 21;28(47):6702–6715. doi: 10.3748/wjg.v28.i47.6702

Figure 5.

Figure 5

Pathophysiology of functional dyspepsia and possible mechanisms of the effects of LG21 treatment. SIBO: Small intestinal bacterial overgrowth; LPS: Lipopolysaccharide.